echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Eur Urol: B7-H3 can be used as a therapeutic target for advanced prostate cancer

    Eur Urol: B7-H3 can be used as a therapeutic target for advanced prostate cancer

    • Last Update: 2022-09-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    B7-H3 is a cell surface immunomodulatory glycoprotein
    that is overexpressed in prostate cancer (PC).


    Recently, researchers from the United Kingdom published an article in Eur Urol investigating the expression of B7-H3 in hormone-sensitive (HSPC) and castration-resistant (CRPC) PC biopsy tissues in the same patient and linked
    to PC genomics.


    The researchers performed immunohistochemistry and next-generation sequencing of 98 clinically annotated CRPC living tissues, including 72 patients who
    also had HSPC living tissue.


    The study found that B7-H3 is one of
    the most highly expressed immunomodulatory genes in CRPCs.


    Anti-tumor activity of anti-B7-H3 ADCs in human CRPC models

    Taken together, B7-H3 is often overexpressed in CRPC compared to normal tissues and other members of the B7 family, meaning it may be a highly probable therapeutic target for these diseases
    .


    Original Source:

    Christina Guo, Ines Figueiredo, Bora Gurel et al.


     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.